Martin Joseph Joyce, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 4,444 shares at $4.50 ($20K) on 2017-02-17, disclosed to the SEC on 2017-02-21.
Open-market purchase of $20k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| ALDX | BUY | 2014-08-07 | $4K | — | Filing → |
| ALDX | BUY | 2014-05-08 | $100K | — | Filing → |
| BSMD | BUY | 2006-06-05 | $1K | — | Filing → |